**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D. C.  20549**

**FORM 10-QSB**

 

[ x ]  Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended** June 30, 2006**or

 

[   ]  Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ______ to ______

 

**1-9731**

*(Commission file No.)*

 

**ARRHYTHMIA RESEARCH TECHNOLOGY, INC.**

*(Exact name of small business issuer as specified in its charter)*

 

| **DELAWARE**                                                      | **72-0925679**                           |
|-------------------------------------------------------------------|------------------------------------------|
| *(State or other jurisdiction of incorporation or  organization)* | *(I.R.S. employer identification no.)*** |

 

**25 Sawyer Passway**

**Fitchburg, Massachusetts  01420**

*(Address of principal executive offices)*

 

**(978) 345-5000**

*(Issuer's telephone number, including area code)*

 

 

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   X   No___.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes _ No X

As of July 31, 2006 there were 2,668,194 shares of the Company’s common stock outstanding.

 

| Transitional Small Business Disclosure Format | Yes | No  X   |
|-----------------------------------------------|-----|--------------|

 

 

 

 

**ARRHYTHMIA RESEARCH TECHNOLOGY, INC.**

TABLE OF CONTENTS

FORM 10-QSB

June 30, 2006

| **PART I - FINANCIAL INFORMATION** | **  1** |  
 

**Item 1. Consolidated Financial Statements**

**  1**

 
 

**Consolidated Balance Sheets**

**  1**

 
 

**Consolidated Statements of Income**

**  2**

 
 

**Consolidated Statements of Cash Flows**

**  3**

 
 

**Notes to the Consolidated Financial Statements**

**  4**

 
 

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

**  6**

 
 

**Item 3. Controls and Procedures**

**  9**

 
**PART II - OTHER INFORMATION**

**10**

 
 

**Item 4. Submission of Matters to a Vote of Security Holders**

**10**

 
 

**Item 6. Exhibits**

**10**

 
 

**SIGNATURES**

**10**

  |
|------------------------------------|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|